| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.3 | 0.03 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.079 | 0.04 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.12 | 0.04 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.08 | 0.04 |